KR20220151952A - Cosmetic composition for skin improvement using houttuynia cordata - Google Patents
Cosmetic composition for skin improvement using houttuynia cordata Download PDFInfo
- Publication number
- KR20220151952A KR20220151952A KR1020210059311A KR20210059311A KR20220151952A KR 20220151952 A KR20220151952 A KR 20220151952A KR 1020210059311 A KR1020210059311 A KR 1020210059311A KR 20210059311 A KR20210059311 A KR 20210059311A KR 20220151952 A KR20220151952 A KR 20220151952A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- weight
- parts
- skin
- cosmetic composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 49
- 239000002537 cosmetic Substances 0.000 title claims abstract description 46
- 230000006872 improvement Effects 0.000 title claims abstract description 36
- 240000000691 Houttuynia cordata Species 0.000 title abstract description 8
- 235000013719 Houttuynia cordata Nutrition 0.000 title abstract description 8
- 239000000284 extract Substances 0.000 claims abstract description 81
- 241001123633 Galactomyces Species 0.000 claims abstract description 26
- 241000675108 Citrus tangerina Species 0.000 claims abstract description 20
- 229940059958 centella asiatica extract Drugs 0.000 claims abstract description 20
- 239000009141 Houttuynia cordata plant extract Substances 0.000 claims abstract description 8
- 239000000843 powder Substances 0.000 claims description 35
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 21
- 240000006891 Artemisia vulgaris Species 0.000 claims description 16
- 239000011148 porous material Substances 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 12
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims description 10
- 229940121363 anti-inflammatory agent Drugs 0.000 claims description 10
- 239000002260 anti-inflammatory agent Substances 0.000 claims description 10
- 238000001914 filtration Methods 0.000 claims description 9
- 235000019866 hydrogenated palm kernel oil Nutrition 0.000 claims description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 8
- 239000003638 chemical reducing agent Substances 0.000 claims description 6
- 239000003795 chemical substances by application Substances 0.000 claims description 6
- 235000020710 ginseng extract Nutrition 0.000 claims description 6
- 235000011511 Diospyros Nutrition 0.000 claims description 5
- 244000236655 Diospyros kaki Species 0.000 claims description 5
- 240000004922 Vigna radiata Species 0.000 claims description 5
- 235000010721 Vigna radiata var radiata Nutrition 0.000 claims description 5
- 235000011469 Vigna radiata var sublobata Nutrition 0.000 claims description 5
- 240000001417 Vigna umbellata Species 0.000 claims description 5
- 235000011453 Vigna umbellata Nutrition 0.000 claims description 5
- 235000021329 brown rice Nutrition 0.000 claims description 5
- 238000002347 injection Methods 0.000 claims description 5
- 239000007924 injection Substances 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 4
- 241000219295 Portulaca Species 0.000 claims description 4
- 239000004310 lactic acid Substances 0.000 claims description 4
- 235000014655 lactic acid Nutrition 0.000 claims description 4
- 240000008620 Fagopyrum esculentum Species 0.000 claims 2
- 244000111489 Gardenia augusta Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 30
- 230000003020 moisturizing effect Effects 0.000 abstract description 14
- 230000037394 skin elasticity Effects 0.000 abstract description 13
- 201000004624 Dermatitis Diseases 0.000 abstract description 8
- 230000002265 prevention Effects 0.000 abstract description 5
- 230000009759 skin aging Effects 0.000 abstract description 5
- 230000002087 whitening effect Effects 0.000 abstract description 5
- 235000003106 Artemisia campestris Nutrition 0.000 abstract 1
- 241001249193 Artemisia campestris Species 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 77
- 238000002360 preparation method Methods 0.000 description 21
- 238000002156 mixing Methods 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 241000219051 Fagopyrum Species 0.000 description 8
- 239000007787 solid Substances 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 235000003826 Artemisia Nutrition 0.000 description 5
- 244000030166 artemisia Species 0.000 description 5
- 235000009052 artemisia Nutrition 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 240000001972 Gardenia jasminoides Species 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 240000004371 Panax ginseng Species 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- -1 afzerin Chemical compound 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 230000001882 diuretic effect Effects 0.000 description 3
- 230000001747 exhibiting effect Effects 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- KTFPZTCBZNFIPH-UHFFFAOYSA-N 1,2,4-trimethoxy-7h-dibenzo[de,g]quinolin-7-one Chemical compound O=C1C2=CC=CC=C2C2=C(OC)C(OC)=CC3=C(OC)C=NC1=C32 KTFPZTCBZNFIPH-UHFFFAOYSA-N 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 241000208838 Asteraceae Species 0.000 description 2
- 206010003645 Atopy Diseases 0.000 description 2
- 244000146462 Centella asiatica Species 0.000 description 2
- 235000004032 Centella asiatica Nutrition 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 241001071917 Lithospermum Species 0.000 description 2
- WYQVAPGDARQUBT-FGWHUCSPSA-N Madecassol Chemical compound O([C@@H]1[C@@H](CO)O[C@H]([C@@H]([C@H]1O)O)OC[C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)[C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4[C@](C)(CO)[C@@H](O)[C@H](O)C[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)[C@@H]1O[C@@H](C)[C@H](O)[C@@H](O)[C@H]1O WYQVAPGDARQUBT-FGWHUCSPSA-N 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- 244000234609 Portulaca oleracea Species 0.000 description 2
- 235000001855 Portulaca oleracea Nutrition 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 2
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- WYQVAPGDARQUBT-XCWYDTOWSA-N asiaticoside Natural products O=C(O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@H](O)[C@H](O)[C@H](O[C@H]3[C@H](O)[C@H](O)[C@@H](O)[C@H](C)O3)[C@@H](CO)O2)O1)[C@@]12[C@@H]([C@@H](C)[C@H](C)CC1)C=1[C@](C)([C@@]3(C)[C@@H]([C@@]4(C)[C@H]([C@@](CO)(C)[C@@H](O)[C@H](O)C4)CC3)CC=1)CC2 WYQVAPGDARQUBT-XCWYDTOWSA-N 0.000 description 2
- 229940022757 asiaticoside Drugs 0.000 description 2
- QCYLIQBVLZBPNK-UHFFFAOYSA-N asiaticoside A Natural products O1C(C(=O)C(C)C)=CC(C)C(C2(C(OC(C)=O)CC34C5)C)C1CC2(C)C3CCC(C1(C)C)C45CCC1OC1OCC(O)C(O)C1O QCYLIQBVLZBPNK-UHFFFAOYSA-N 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000002934 diuretic Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000003344 environmental pollutant Substances 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- BUWCHLVSSFQLPN-UHFFFAOYSA-N madecassic acid Natural products CC1CCC2(CCC3(C)C(=CCC4C5(C)CC(O)C(O)C(C)(C5CCC34C)C(=O)O)C2C1C)C(=O)OC6OC(COC7OC(CO)C(OC8OC(C)C(O)C(O)C8O)C(O)C7O)C(O)C(O)C6O BUWCHLVSSFQLPN-UHFFFAOYSA-N 0.000 description 2
- PRAUVHZJPXOEIF-AOLYGAPISA-N madecassic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2[C@H](O)C[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C PRAUVHZJPXOEIF-AOLYGAPISA-N 0.000 description 2
- 229940011656 madecassic acid Drugs 0.000 description 2
- 239000002075 main ingredient Substances 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- BAGGDUOPTSQTHD-UHFFFAOYSA-N norcepharadione b Chemical compound C1=CC=C2C3=C(OC)C(OC)=CC(C(=O)C(=O)N4)=C3C4=CC2=C1 BAGGDUOPTSQTHD-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 231100000719 pollutant Toxicity 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 2
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 2
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- IMWRTDKZVXEHLE-QGZVFWFLSA-N 2-[[5-chloro-2-[2-methoxy-4-[(3r)-3-(methylamino)pyrrolidin-1-yl]anilino]pyrimidin-4-yl]amino]-n-propan-2-ylbenzenesulfonamide Chemical compound C1[C@H](NC)CCN1C(C=C1OC)=CC=C1NC1=NC=C(Cl)C(NC=2C(=CC=CC=2)S(=O)(=O)NC(C)C)=N1 IMWRTDKZVXEHLE-QGZVFWFLSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- NEZONWMXZKDMKF-JTQLQIEISA-N Alkannin Chemical compound C1=CC(O)=C2C(=O)C([C@@H](O)CC=C(C)C)=CC(=O)C2=C1O NEZONWMXZKDMKF-JTQLQIEISA-N 0.000 description 1
- KPVDACWQNCRKTG-UHFFFAOYSA-N Aristololactam II Natural products C=1C(C(=O)N2)=C3C2=CC2=CC=CC=C2C3=C2OCOC2=1 KPVDACWQNCRKTG-UHFFFAOYSA-N 0.000 description 1
- DJHGAFSJWGLOIV-UHFFFAOYSA-N Arsenic acid Chemical compound O[As](O)(O)=O DJHGAFSJWGLOIV-UHFFFAOYSA-N 0.000 description 1
- 241000092668 Artemisia capillaris Species 0.000 description 1
- 235000008658 Artemisia capillaris Nutrition 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- DBNFUUYMTAGFDM-UHFFFAOYSA-N Cepharadione B Natural products C1=CC=C2C3=C(OC)C(OC)=CC(C(=O)C(=O)N4)=C3C4=C(Cl)C2=C1 DBNFUUYMTAGFDM-UHFFFAOYSA-N 0.000 description 1
- AFKGBLKLNRDQFN-UHFFFAOYSA-N Cepharadione B Chemical compound C1=CC=C2C3=C(OC)C(OC)=CC(C(=O)C(=O)N4C)=C3C4=CC2=C1 AFKGBLKLNRDQFN-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- OVSQVDMCBVZWGM-IDRAQACASA-N Hirsutrin Natural products O([C@H]1[C@H](O)[C@H](O)[C@H](O)[C@@H](CO)O1)C1=C(c2cc(O)c(O)cc2)Oc2c(c(O)cc(O)c2)C1=O OVSQVDMCBVZWGM-IDRAQACASA-N 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 208000008574 Intracranial Hemorrhages Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- KBGNBPGXVKPRQI-UHFFFAOYSA-N Piperolactam A Chemical compound C1=CC=C2C3=C(O)C(OC)=CC(C(=O)N4)=C3C4=CC2=C1 KBGNBPGXVKPRQI-UHFFFAOYSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- WNFXUXZJJKTDOZ-HNNXBMFYSA-N [(1s)-1-(5,8-dihydroxy-1,4-dioxonaphthalen-2-yl)-4-methylpent-3-enyl] acetate Chemical compound C1=CC(O)=C2C(=O)C([C@@H](OC(C)=O)CC=C(C)C)=CC(=O)C2=C1O WNFXUXZJJKTDOZ-HNNXBMFYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- UNNKKUDWEASWDN-UHFFFAOYSA-N alkannin Natural products CC(=CCC(O)c1cc(O)c2C(=O)C=CC(=O)c2c1O)C UNNKKUDWEASWDN-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000954 anitussive effect Effects 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 229940124599 anti-inflammatory drug Drugs 0.000 description 1
- 230000003097 anti-respiratory effect Effects 0.000 description 1
- 229930187117 aristolactam Natural products 0.000 description 1
- MXOKGWUJNGEKBH-UHFFFAOYSA-N aristololactam Chemical compound COC1=CC=CC(C2=C34)=C1C=C3NC(=O)C4=CC1=C2OCO1 MXOKGWUJNGEKBH-UHFFFAOYSA-N 0.000 description 1
- 229940000488 arsenic acid Drugs 0.000 description 1
- JXSVIVRDWWRQRT-UYDOISQJSA-N asiatic acid Chemical compound C1[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C JXSVIVRDWWRQRT-UYDOISQJSA-N 0.000 description 1
- 229940011658 asiatic acid Drugs 0.000 description 1
- LBGFKBYMNRAMFC-PYSQTNCISA-N asiatic acid Natural products C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC[C@@H]4[C@@]5(C)C[C@@H](O)[C@H](O)[C@@](C)(CO)[C@@H]5CC[C@@]34C)[C@]2(C)[C@H]1C)C(=O)O LBGFKBYMNRAMFC-PYSQTNCISA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- CLXOLTFMHAXJST-UHFFFAOYSA-N esculentic acid Natural products C12CC=C3C4CC(C)(C(O)=O)CCC4(C(O)=O)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(CO)C CLXOLTFMHAXJST-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000576 food coloring agent Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 206010020488 hydrocele Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- OVSQVDMCBVZWGM-QCKGUQPXSA-N isoquercetin Natural products OC[C@@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@@H]1O OVSQVDMCBVZWGM-QCKGUQPXSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- KOHJULKXWHILSZ-UHFFFAOYSA-N piperolactam A Natural products COc1cc2C(=O)Nc3cc4ccc(O)cc4c(c1)c23 KOHJULKXWHILSZ-UHFFFAOYSA-N 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000001047 purple dye Substances 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- OVSQVDMCBVZWGM-QSOFNFLRSA-N quercetin 3-O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-QSOFNFLRSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- WNFXUXZJJKTDOZ-UHFFFAOYSA-N shikonin acetate Natural products C1=CC(O)=C2C(=O)C(C(OC(C)=O)CC=C(C)C)=CC(=O)C2=C1O WNFXUXZJJKTDOZ-UHFFFAOYSA-N 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 229940030961 sorghum extract Drugs 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000002371 ultraviolet--visible spectrum Methods 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9728—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 어성초를 이용한 피부개선용 화장료 조성물에 관한 것으로, 더욱 상세하게는 피부 탄력, 피부 진정, 피부 노화방지, 피부 미백 및 피부 보습 효과를 나타낼 뿐만 아니라, 피부 염증을 개선하는 효과를 나타내는 어성초를 이용한 피부개선용 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition for skin improvement using Hoseongcho, and more particularly, Houttuynia cordata, which not only exhibits skin elasticity, skin soothing, skin aging prevention, skin whitening and skin moisturizing effects, but also exhibits an effect of improving skin inflammation. It relates to a cosmetic composition for skin improvement.
인체는 약 70 내지 75% 정도의 수분을 함유하고 있으며, 피부는 다양한 외부 자극으로부터 몸을 보호함과 동시에 체내 수분손실을 막는 장벽 기능을 가지고 있다. 피부에는 유분과 함께 수분이 존재하며, 피부에 함유된 수분량은 15 내지 20%를 나타낸다.The human body contains about 70 to 75% of water, and the skin has a barrier function that protects the body from various external stimuli and at the same time prevents water loss in the body. Moisture exists in the skin along with oil, and the amount of moisture contained in the skin represents 15 to 20%.
피부의 각질층은 과도한 세안이나, 목욕 등의 생활 습관적 요인, 건조한 대기, 오염물질 등의 환경적인 요인 또는 아토피성 피부나 노인성 피부 같은 내인성 요인 등으로 인해 쉽게 그 기능이 손실될 수 있는데, 이로 인해 각질층의 수분이 감소하여 피부가 건조해지고 피부 표면이 거칠게 되며, 경우에 따라서는 피부 갈라짐 현상이 나타나기도 한다.The stratum corneum of the skin can easily lose its function due to lifestyle factors such as excessive washing or bathing, environmental factors such as dry air and pollutants, or endogenous factors such as atopic skin or aged skin. As the moisture of the skin decreases, the skin becomes dry, the skin surface becomes rough, and in some cases, the skin cracks appear.
특히, 현대 사회에 들어서 공해 물질 등의 여러 요인들로 인해 성인 아토피, 건선 등과 같은 피부질환을 호소하는 사람들이 증가하고 있으며, 이에 따라, 적절한 피부 수분을 유지하기 위해 수분 공급량을 증가시키거나, 체내로부터의 수분 손실을 방지하기 위한 연구가 지속적으로 이루어지고 있다.In particular, an increasing number of people complaining of skin diseases such as atopy and psoriasis in adults due to various factors such as pollutants in modern society. Research is being continuously conducted to prevent water loss from
실제로 수분보유능력이 있는 여러 종류의 보습제(Moisturizer)가 개발되고 있는데, 일반적으로 다양한 화장료 조성물들은 피부의 건조함을 극복하기 위해 오일, 당 및 폴리올 등 다양한 보습제를 이용하여 피부의 건조함을 개선하고자 노력하고 있다. 피부 구성 성분인 세라마이드, 콜레스테롤 및 지방산 등을 이용하여 피부 장벽 기능을 강화함으로서 피부로부터 수분의 증발을 억제하거나 피부 표면에서 수분과 결합하는 능력이 강한 당 및 폴리올 등을 이용해 피부 수분 보유 능력을 강화하는 노력이 이루어지고 있다.In fact, various types of moisturizers with the ability to retain moisture are being developed. In general, various cosmetic compositions are used to improve dryness of the skin by using various moisturizers such as oil, sugar, and polyol to overcome dryness of the skin. Trying hard. Suppresses evaporation of moisture from the skin by strengthening the skin barrier function by using skin constituents such as ceramide, cholesterol and fatty acids, or strengthens the skin's ability to retain moisture by using sugars and polyols that have a strong ability to combine with moisture on the skin surface. Efforts are being made.
그러나, 종래에 화장료 조성물은 상대적으로 습도가 낮은 겨울철에는 그 효과를 오랫 동안 지속시키기가 어렵고, 상대적으로 습도가 높은 여름철에는 오히려 불쾌감을 주어 습도의 변화에 따른 적절한 화장료 조성물의 제조에 어려움이 있었으며, 보습효과와 피부염증을 동시에 개선하는 화장료 조성물에 대해서는 기재된 바가 없다.However, in the conventional cosmetic composition, it is difficult to maintain the effect for a long time in winter when the humidity is relatively low, and it is rather unpleasant in summer when the humidity is relatively high, making it difficult to prepare an appropriate cosmetic composition according to the change in humidity. There is no description about a cosmetic composition that simultaneously improves moisturizing effect and skin inflammation.
본 발명의 목적은 피부 탄력, 피부 진정, 피부 노화방지, 피부 미백 및 피부 보습 효과를 나타낼 뿐만 아니라, 피부 염증을 개선하는 효과를 나타내는 어성초를 이용한 피부개선용 화장료 조성물을 제공하는 것이다.An object of the present invention is to provide a cosmetic composition for skin improvement using Houttuynia cordata, which exhibits skin elasticity, skin soothing, skin aging prevention, skin whitening and skin moisturizing effects, as well as improving skin inflammation.
본 발명의 목적은 어성초 추출물, 병풀 추출물, 인진쑥 추출물, 청귤 추출물 및 갈락토미세스 발효물로 이루어지는 것을 특징으로 하는 어성초를 이용한 피부개선용 화장료 조성물을 제공함에 의해 달성된다.An object of the present invention is achieved by providing a cosmetic composition for skin improvement using Hoseongcho, characterized in that it consists of a Hoseongcho extract, Centella Asiatica extract, Injin mugwort extract, a green tangerine extract, and a fermented product of Galactomyces.
본 발명의 바람직한 특징에 따르면, 상기 어성초를 이용한 피부개선용 화장료 조성물은 어성초 추출물 100 중량부, 병풀추출물 5 내지 20 중량부, 인진쑥 추출물 5 내지 20 중량부, 청귤 추출물 5 내지 10 중량부 및 갈락토미세스 발효물 0.1 내지 5 중량부로 이루어지는 것으로 한다.According to a preferred feature of the present invention, the cosmetic composition for skin improvement using the eoseongcho extract 100 parts by weight of eoseongcho extract, 5 to 20 parts by weight of centella asiatica extract, 5 to 20 parts by weight of artemisia extract, 5 to 10 parts by weight of green tangerine extract and galacto It is made of 0.1 to 5 parts by weight of Mrs. fermented product.
본 발명의 더 바람직한 특징에 따르면, 상기 갈락토미세스 발효물은 갈락토미세스에 유산균을 접종하고, 20 내지 40℃의 온도에서 20 내지 30시간 동안 발효하여 발효물을 제조한 후에, 상기 발효물에 함유된 균체를 파쇄한 후에 원심분리 및 여과하여 제조되는 것으로 한다.According to a more preferred feature of the present invention, the fermented product of Galactomyces is prepared by inoculating lactic acid bacteria into Galactomyces and fermenting at a temperature of 20 to 40 ° C. for 20 to 30 hours to prepare a fermented product. It is intended to be prepared by crushing the contained cells, followed by centrifugation and filtration.
본 발명의 더욱 바람직한 특징에 따르면, 상기 어성초를 이용한 피부개선용 화장료 조성물에는 상기 어성초 추출물 100 중량부 대비 자초 추출물이 함유된 천연 항염제 1 내지 3 중량부 및 메밀이 함유된 천연 모공 축소제 2 내지 5 중량부가 더 함유되는 것으로 한다.According to a more preferred feature of the present invention, in the cosmetic composition for skin improvement using the Houttuynia cordata extract, 1 to 3 parts by weight of a natural anti-inflammatory agent containing a self-injection extract and 2 to 5 natural pore reducing agents containing buckwheat relative to 100 parts by weight of the Houttuynia cordata extract It is assumed that the weight part is further contained.
본 발명의 더욱 더 바람직한 특징에 따르면, 상기 천연 항염제는 자초 추출물, 치자 추출물, 연교 추출물, 고삼 추출물, 현삼 추출물 및 마치현 추출물로 이루어지는 것으로 한다.According to a more preferred feature of the present invention, the natural anti-inflammatory agent is composed of self-inflicted extract, gardenia extract, yeongyo extract, sorghum extract, ginseng extract, and portulaca extract.
본 발명의 더욱 더 바람직한 특징에 따르면, 상기 천연 모공 축소제는 메밀 분말, 녹두 분말, 팥 분말, 율피 분말, 현미 분말, 감잎 분말 및 백지 분말로 이루어지는 것으로 한다.According to a more preferred feature of the present invention, the natural pore shrinking agent is made of buckwheat powder, mung bean powder, red bean powder, yulpi powder, brown rice powder, persimmon leaf powder, and white paper powder.
본 발명의 더욱 더 바람직한 특징에 따르면, 상기 어성초를 이용한 피부개선용 화장료 조성물에는 상기 어성초 추출물 100 중량부 대비 수소화 팜 커널 오일 1 내지 5 중량부가 더 함유되는 것으로 한다.According to a more preferred feature of the present invention, the cosmetic composition for skin improvement using the Houttuynia cordata further contains 1 to 5 parts by weight of hydrogenated palm kernel oil relative to 100 parts by weight of the Houttuynia cordata extract.
본 발명에 따른 어성초를 이용한 피부개선용 화장료 조성물은 피부 탄력, 피부 진정, 피부 노화방지, 피부 미백 및 피부 보습 효과를 나타낼 뿐만 아니라, 피부 염증을 개선하는 탁월한 효과를 나타낸다.The cosmetic composition for skin improvement using Eoseongcho according to the present invention not only exhibits skin elasticity, skin soothing, skin aging prevention, skin whitening and skin moisturizing effects, but also exhibits an excellent effect of improving skin inflammation.
이하에는, 본 발명의 바람직한 실시예와 각 성분의 물성을 상세하게 설명하되, 이는 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자가 발명을 용이하게 실시할 수 있을 정도로 상세하게 설명하기 위한 것이지, 이로 인해 본 발명의 기술적인 사상 및 범주가 한정되는 것을 의미하지는 않는다.Hereinafter, a preferred embodiment of the present invention and the physical properties of each component will be described in detail, but this is to be explained in detail so that a person having ordinary knowledge in the art to which the present invention belongs can easily practice the invention, This is not meant to limit the technical spirit and scope of the present invention.
본 발명에 따른 어성초를 이용한 피부개선용 화장료 조성물은 어성초 추출물, 병풀 추출물, 인진쑥 추출물, 청귤 추출물 및 갈락토미세스 발효물로 이루어지며, 어성초 추출물 100 중량부, 병풀추출물 5 내지 20 중량부, 인진쑥 추출물 5 내지 20 중량부, 청귤 추출물 5 내지 10 중량부 및 갈락토미세스 발효물 0.1 내지 5 중량부로 이루어지는 것이 바람직하다.The cosmetic composition for skin improvement using eoseongcho according to the present invention consists of eoseongcho extract, centella asiatica extract, injin mugwort extract, green tangerine extract, and galactomyces fermented product, 100 parts by weight of eoseongcho extract, 5 to 20 parts by weight of centella asiatica extract, injin mugwort extract It is preferably composed of 5 to 20 parts by weight, 5 to 10 parts by weight of green tangerine extract, and 0.1 to 5 parts by weight of fermented Galactomyces.
상기 어성초 추출물은 정제수로 수세한 어성초(산지) 100 중량부 대비 질량농도가 95%인 에탄올 500 내지 700 중량부를 혼합하고 상온에서 12 내지 15시간 동안 추출한 후에 고형분을 여과하는 과정을 통해 제조된다.The Eoseongcho extract is prepared by mixing 500 to 700 parts by weight of ethanol having a mass concentration of 95% with respect to 100 parts by weight of Eoseongcho (sanji) washed with purified water, extracting at room temperature for 12 to 15 hours, and filtering the solid content.
상기 어성초(Houttuynia cordata Thunberg)는 삼백초과에 속하며, 약모밀의 개화기의 지상부를 의미하는 것으로서, 잎을 부수면 고기 비린내가 나기 때문에 붙여진 이름이며 맛은 약간 떫다. 전통약용식물로서 청열해독, 이뇨 소종하는 효능이 있고 폐농양, 담열해수, 폐렴, 수종, 각기, 요로감염, 백대하, 과다, 용종, 창독에 외용한다고 알려져 있다. 크게 열을 내리고 해독하며 이뇨하고 부기를 가라앉히는 효능을 가진다. 어성초의 약리작용으로 항균작용, 면역증강작용, 항염증작용, 이뇨작용 및 진해작용이 보고되었다.The eoseongcho (Houttuynia cordata Thunberg) belongs to the family of more than three hundred, and refers to the above-ground part of the flowering period of medicinal wheat. As a traditional medicinal plant, it has the effect of detoxification of heat and diuresis, and is known to be used externally for lung abscess, phlegmon seawater, pneumonia, hydrocele, beriberi, urinary tract infection, leukemia, overdose, polyp, and phlegm. It has the effect of greatly lowering fever, detoxifying, diuretic, and relieving swelling. As pharmacological actions of Eoseongcho, antibacterial action, immune enhancing action, anti-inflammatory action, diuretic action and antitussive action have been reported.
주요 성분으로는 Flavonoid로서 quercetin, quercitrin, isoquercetin, afzerin, rutin , Alkaloid로서 aristolactam A, AII, B, BII, piperolactam A, norcepharadione B, cepharadione B, splendidine 등이 보고되어 있다. 이 중에서도 어성초의 주성분은 Quercitrin으로 간보호, 항알러지 호흡기 조절 등 다양한 생리활성 기능이 있는 것으로 보고 되었다.Flavonoids such as quercetin, quercitrin, isoquercetin, afzerin, rutin, and alkaloids such as aristolactam A, AII, B, BII, piperolactam A, norcepharadione B, cepharadione B, and splendidine have been reported. Among them, the main ingredient of Eoseongcho is Quercitrin, which has been reported to have various physiological activities such as liver protection, anti-allergy and respiratory control.
상기의 효능을 나타내는 어성초 추출물은 피부에 적용되면, 노폐물 배출 작용, 피부 항산화 등의 효과를 나타낸다.Eoseongcho extract exhibiting the above effects, when applied to the skin, exhibits effects such as waste discharge and skin antioxidant.
상기 병풀추출물은 5 내지 20 중량부가 함유되며, 건조된 병풀 잎 100 중량부를 2 내지 3cm로 절단하고, 질량농도가 30%인 에탄올 800 내지 1200 중량부를 혼합하고 상온에서 4 내지 6일 동안 침적시키고, 고형분을 여과하는 과정을 통해 제조된다.The Centella asiatica extract contains 5 to 20 parts by weight, 100 parts by weight of dried centella asiatica leaves are cut into 2 to 3 cm, mixed with 800 to 1200 parts by weight of ethanol having a mass concentration of 30%, and deposited at room temperature for 4 to 6 days, It is prepared through the process of filtering solids.
상기 병풀 추출물에는 아시아티코사이드(asiaticoside), 마데카식 애시드(madecassic acid), 아시아틱 애시드(asiatic acid)가 주성분으로 함유되어 있으며, 피부 상처 및 만성 궤양 치료 활성 등을 나타낸다. 아시아티코사이드와 마데카식 애시드는 콜라겐의 생성과 분비에 관여를 하며, 이에 따라 상처받은 피부 재생과 진피의 탄력을 높이는데 효능이 있다고 알려져 있다. 또한, 최근 들어 의약품뿐만 아니라 기능성 화장품 소재로 사용하기 위한 수요가 증가하고 있다.The centella asiatica extract contains asiaticoside, madecassic acid, and asiatic acid as main components, and exhibits skin wound and chronic ulcer treatment activity. Asiaticoside and madecassic acid are involved in the production and secretion of collagen, and are known to be effective in regenerating damaged skin and increasing the elasticity of the dermis. In addition, recently, demand for use as a material for functional cosmetics as well as pharmaceuticals has increased.
상기의 효능을 나타내는 병풀추출물은 피부에 적용되면, 피부 회복, 피부 탄력 증진 및 피부진정에 도움을 주며, 피부 항산화작용을 통해 노화를 방지하는 역할을 하는데, 상기 병풀 추출물의 함량이 5 중량부 미만이면 상기의 효과가 미미하며, 상기 병풀추출물의 함량이 20 중량부를 초과하게 되면 상기의 효과는 크게 향상되지 않으면서 제조비용을 증가시키게 된다.Centella asiatica extract, which exhibits the above effects, when applied to the skin, helps in skin recovery, skin elasticity enhancement and skin soothing, and serves to prevent aging through skin antioxidant action, and the content of the centella asiatica extract is less than 5 parts by weight. If the above effect is insignificant, when the content of the Centella asiatica extract exceeds 20 parts by weight, the above effect is not greatly improved and the manufacturing cost increases.
상기 인진쑥 추출물은 5 내지 20 중량부가 함유되며, 건조된 인진쑥 100 중량부를 0.1 내지 1cm로 분쇄하고, 질량농도가 50%인 프로필렌글리콜 500 내지 700 중량부를 혼합하고 상온에서 4 내지 6일 동안 침적시키고, 고형분을 여과하는 과정을 통해 제조된다.The Injin mugwort extract contains 5 to 20 parts by weight, and 100 parts by weight of dried Injin mugwort is pulverized to a size of 0.1 to 1 cm, mixed with 500 to 700 parts by weight of propylene glycol having a mass concentration of 50%, and deposited at room temperature for 4 to 6 days, It is prepared through the process of filtering solids.
상기 인진쑥(Artemisia capillaris)은 우리나라에서 자생하는 식물로 국화과(compositae)의 다년생 초본 식물이며, 더위지기, 애탕쑥이라고도 불린다. 인진쑥은 주로 어린순이 사용되며, 항염, 항균, 항여드름, 항산화, 이뇨제 및 황달 등에 효과가 있는 것으로 알려져 있다. 주요 성분으로는 폴리페놀의 일종인 클로로겐산(chlorogenic acid), 카페익산(caffeic acid)부터 정유 성분인 올레산(oleic acid), 리놀레산(linoleic acid)까지 다양한 성분들이 포함되어 있다.The artemisia capillaris is a plant native to Korea and is a perennial herbaceous plant of the Asteraceae family (compositae), and is also called a heat keeper and a loveworm. Injin mugwort is mainly used for young shoots, and is known to be effective in anti-inflammatory, antibacterial, anti-acne, antioxidant, diuretic and jaundice. The main components include various components, from chlorogenic acid and caffeic acid, which are types of polyphenols, to oleic acid and linoleic acid, which are essential oil components.
상기의 효능을 나타내는 인진쑥 추출물이 피부에 적용되면 붉은 피부를 개선시켜 피부톤을 개선하는 효과를 나타낼 뿐만 아니라, 피부 정화 효과를 나타낸다.When the ginseng mugwort extract exhibiting the above efficacy is applied to the skin, it not only shows the effect of improving skin tone by improving red skin, but also shows a skin purification effect.
상기 인진쑥 추출물의 함량이 5 중량부 미만이면 상기의 효과가 미미하며, 상기 인진쑥 추출물의 함량이 20 중량부를 초과하게 되면 상기의 효과는 크게 향상되지 않으면서 제조비용을 증가시키게 된다.If the content of the ginger mugwort extract is less than 5 parts by weight, the above effects are insignificant, and if the content of the ginger mugwort extract exceeds 20 parts by weight, the above effects are not greatly improved and the manufacturing cost increases.
상기 청귤 추출물은 5 내지 10 중량부가 함유되며, 건조된 청귤 100 중량부를 분쇄한 후에, 정제수 500 내지 1000 중량부를 혼합하고 10 내지 15시간 동안 환류추출한 후에 여과하는 과정으로 제조된다.The green tangerine extract contains 5 to 10 parts by weight, and is prepared by pulverizing 100 parts by weight of dried green tangerines, mixing 500 to 1000 parts by weight of purified water, extracting under reflux for 10 to 15 hours, and filtering.
상기의 과정을 통해 제조되는 청귤 추출물이 피부에 적용되면 피부톤을 개선하고, 잡티를 줄여주며 우수한 피부 보습력으로 인해 촉촉한 피부를 제공하는 역할을 하는데, 상기 청귤 추출물의 함량이 5 중량부 미만이면 상기의 효과가 미미하며, 상기 청귤 추출물의 함량이 10 중량부를 초과하게 되면 상기의 효과는 크게 향상되지 않으면서 상대적으로, 어성초 추출물, 병풀 추출물, 인진쑥 추출물 및 갈락토미세스 발효물의 함량이 줄어들기 때문에 바람직하지 못하다.When the green tangerine extract prepared through the above process is applied to the skin, it improves skin tone, reduces blemishes, and provides moist skin due to excellent skin moisturizing power. If the content of the green tangerine extract is less than 5 parts by weight, the above The effect is insignificant, and when the content of the green tangerine extract exceeds 10 parts by weight, the above effects are not greatly improved, and the contents of the Houttuynia cordata extract, Centella asiatica extract, Artemisia extract, and Galactomyces fermented product are relatively reduced, which is not preferable. Can not do it.
상기 갈락토미세스(Galactomyses) 발효물은 0.1 내지 5 중량부가 함유되며, 갈락토미세스에 유산균을 접종하고, 20 내지 40℃의 온도에서 20 내지 30시간 동안 발효하여 발효물을 제조한 후에, 상기 발효물에 함유된 균체를 파쇄한 후에 원심분리 및 여과하여 제조된다.The Galactomyces fermented product contains 0.1 to 5 parts by weight, inoculated with lactic acid bacteria in Galactomyces, and fermented at a temperature of 20 to 40 ° C. for 20 to 30 hours to prepare a fermented product, the fermentation It is prepared by crushing the cells contained in water, followed by centrifugation and filtration.
상기 갈락토미세스는 피테라라고도 불리는 갈락토미세스 효모를 발효시킨 후 여과한 물질로서, 비타민과 미네랄, 아미노산, 효소, 유기산, 효모펩타이드 등이 풍부하여, 묵은 각질 제거와 보습 지속력이 좋아 피부결을 정돈하고, 피부탄력 및 피부톤을 맑게 하는 것으로 알려져 있다. 또한 피부 본연의 리듬과 밸런스를 조정하여 생기있고 건강한 피부로 만들어 주는 천연효모로써 최고의 가치를 인정받고 있다.The Galactomyces is a substance filtered after fermenting Galactomyces yeast, also called Pitera, and is rich in vitamins, minerals, amino acids, enzymes, organic acids, yeast peptides, etc. It is known to brighten skin elasticity and skin tone. In addition, it is recognized as the best value as a natural yeast that adjusts the natural rhythm and balance of the skin to make it lively and healthy.
상기의 과정을 통해 제조되는 갈락토미세스 발효물이 피부에 적용되면 피부자극을 완화하며, 맑고 투명한 피부를 제공할 뿐만 아니라, 보습효과로 인해 촉촉하고 밝은 광채가 나는 피부를 제공할 수 있다.When the Galactomyces fermented product prepared through the above process is applied to the skin, it can relieve skin irritation, provide clear and transparent skin, and provide moist and bright radiant skin due to the moisturizing effect.
상기 갈락토미세스 발효물의 함량이 0.1 중량부 미만이면 상기의 효과가 미미하며, 상기 갈락토미세스 발효물의 함량이 5 중량부를 초과하게 되면 상기의 효과 상승은 크지 않으면서 제조비용을 지나치게 증가시키기 때문에 바람직하지 못하다.If the content of the fermented Galactomyces is less than 0.1 part by weight, the above effect is insignificant, and if the content of the fermented Galactomyces is greater than 5 parts by weight, the increase in the effect is not great and the manufacturing cost is excessively increased, so it is preferable. can't
또한, 본 발명에 따른 어성초를 이용한 피부개선용 화장료 조성물에는 상기 어성초 추출물 100 중량부 대비 자초 추출물이 함유된 천연 항염제 1 내지 3 중량부 및 메밀이 함유된 천연 모공 축소제 2 내지 5 중량부가 더 함유될 수도 있는데, 상기와 같이 천연 항염제와 천연 모공 축소제가 함유되면 모공축소 및 피부염증을 억제하는 효과를 나타내는 화장료 조성물이 제공될 수 있다.In addition, the cosmetic composition for skin improvement using Hoseongcho according to the present invention further contains 1 to 3 parts by weight of a natural anti-inflammatory agent containing a perilla extract and 2 to 5 parts by weight of a natural pore reducing agent containing buckwheat compared to 100 parts by weight of the Hoseongcho extract. It may be, as described above, when a natural anti-inflammatory agent and a natural pore-reducing agent are contained, a cosmetic composition exhibiting the effect of suppressing pore-reduction and skin inflammation can be provided.
성가 천연 항염제에 주성분인 (학명 : Lithospermum erythrorhizon)는 통화식물목 지치과의 여러해살이풀로서 뿌리를 말린 것을 자근(紫根)이라 하며, 한방에서는 이를 해독, 해열, 종창, 화상, 동상, 습진, 물집 등에 사용한다. 민간에서는 불로약(不老藥)으로 사용한다. 옛날에는 자주색 염료 또는 식용색소로 사용하기도 하였다. 건조한 풀밭이나 산지에서 자란다. 한국, 일본, 중국 둥베이[東北(동북)]지방에 걸쳐서 분포하는 것으로 알려져 있다. 특히, 자초는 시코닌(shikonin), 아세틸시코닌(acetyl shikonin) 등과 함께 다당류인 리소스퍼먼 등의 성분을 함유하며, 혈액 순환 촉진 작용, 해독작용, 항균 및 항염작용 등이 있어 각종 창양 종기나 화상, 습진 등을 치료하는데 사용되는 한약재로 알려져 있다. 또한, 매우 강력한 콜라겐 합성 촉진 효과가 있어 피부 주름 개선 효과가 상당히 우수하다.(Scientific name: Lithospermum erythrorhizon), the main ingredient in natural anti-inflammatory drugs, is a perennial plant of the genus Phytophyte, and the dried roots are called purple roots. use etc. In the private sector, it is used as an anti-aging drug. In the past, it was also used as a purple dye or food coloring. It grows in dry grass or mountain areas. It is known to be distributed throughout Korea, Japan, and the Dongbei [東北 (Northeast)] region of China. In particular, self-injection contains ingredients such as shikonin and acetyl shikonin, which are polysaccharides, such as resource perman, and has blood circulation stimulating, detoxifying, antibacterial and anti-inflammatory effects, so it is effective in treating various wounds, boils and burns. It is known as a herbal medicine used to treat eczema, etc. In addition, it has a very strong collagen synthesis promoting effect, so the effect of improving skin wrinkles is quite excellent.
이때, 상기 천연 항염제는 자초 추출물, 치자 추출물, 연교 추출물, 고삼 추출물, 현삼 추출물 및 마치현 추출물로 이루어지는 것이 바람직한데, 자초 추출물 100 중량부, 치자 추출물 5 내지 20 중량부, 연교 추출물 5 내지 20 중량부, 고삼 추출물 5 내지 20 중량부, 현삼 추출물 5 내지 20 중량부 및 마치현 추출물 5 내지 20 중량부로 이루어지는 것이 바람직하며, 상기에 나열된 추출물은 자초, 치자, 연교, 고삼, 현삼 및 마치현 각각 100 중량부 대비 정제수 500 내지 1000 중량부를 혼합하여 80 내지 90℃의 온도에서 20 내지 40분 동안 가열한 후에 고형분을 걸러내는 과정으로 제조된다.At this time, the natural anti-inflammatory agent is preferably composed of self-injection extract, gardenia extract, yeongyo extract, gosam extract, ginseng extract, and portulaca oleracea extract. , It is preferable to consist of 5 to 20 parts by weight of soy ginseng extract, 5 to 20 parts by weight of ginseng extract, and 5 to 20 parts by weight of portulaca oleracea extract, and the extracts listed above are 100 parts by weight of each of ginseng, gardenia, yeongyo, gosam, ginseng and portulaca. It is prepared by mixing 500 to 1000 parts by weight of purified water, heating at a temperature of 80 to 90 ° C. for 20 to 40 minutes, and then filtering out the solid content.
또한, 상기 천연 모공 축소제의 주성분인 메밀은 학명이 파고피럼 에스컬렌텀(Fagopyrum esculentum)이며, 민간에서는 고혈압, 간염을 앓을때에 메밀가루 반죽, 메밀죽을 만들어 먹으며, 루틴은 알약으로 제조하여 모세혈관출혈, 뇌출혈의 예방 및 동맥경화에 효능이 있는 것으로 알려져 있다. 특히, 메밀은 피지와 각질, 노폐물이 쌓여 있는 피부트러블에 효과적이며, 피부 노폐물을 깨끗하게 제거하여 모공이 숨을 쉬도록 하는 작용을 한다.In addition, buckwheat, the main component of the natural pore shrinking agent, has a scientific name of Pagopyrum esculentum. It is known to be effective in preventing blood vessel hemorrhage, brain hemorrhage, and atherosclerosis. In particular, buckwheat is effective for skin troubles accumulated with sebum, dead skin cells, and wastes, and cleanly removes skin wastes to allow pores to breathe.
이때, 상기 천연 모공 축소제는 메밀 분말, 녹두 분말, 팥 분말, 율피 분말, 현미 분말, 감잎 분말 및 백지(白芷) 분말로 이루어지며, 메밀 분말 100 중량부, 녹두 분말 5 내지 20 중량부, 팥 분말 5 내지 20 중량부, 율피 분말 5 내지 20 중량부, 현미 분말 5 내지 20 중량부, 감잎 분말 5 내지 20 중량부 및 백지 분말 5 내지 20 중량부로 이루어지는 것이 바람직하다.At this time, the natural pore reducing agent consists of buckwheat powder, mung bean powder, red bean powder, yulpi powder, brown rice powder, persimmon leaf powder and white paper powder, 100 parts by weight of buckwheat powder, 5 to 20 parts by weight of mung bean powder, red beans It is preferably composed of 5 to 20 parts by weight of powder, 5 to 20 parts by weight of yulpi powder, 5 to 20 parts by weight of brown rice powder, 5 to 20 parts by weight of persimmon leaf powder, and 5 to 20 parts by weight of white paper powder.
또한, 상기 어성초를 이용한 피부개선용 화장료 조성물에는 상기 어성초 추출물 100 중량부 대비 수소화 팜 커널 오일 1 내지 5 중량부가 더 함유될 수도 있는데, 상기와 같이 수소화 팜 커널 오일이 더 함유되면 본 발명에 따른 화장료 조성물의 보습효과가 월등하게 향상될 수 있다.In addition, the cosmetic composition for skin improvement using the Houttuynia cordata may further contain 1 to 5 parts by weight of hydrogenated palm kernel oil relative to 100 parts by weight of the Houttuynia cordata extract. The moisturizing effect of the composition can be significantly improved.
상기 수소화 팜 커널 오일(hydrogenated palm kernel Oil)은 팜 과육의 씨로부터 수득된 팜 커널 오일을 수소화 처리한 것으로, 팜 오일에 비해 장쇄 비장산의 함량이 낮아 피부보습 효과 뿐만 아니라, 피부 탄력 개선에 탁월한 효과를 나타낸다.The hydrogenated palm kernel oil is obtained by hydrogenating palm kernel oil obtained from the seeds of palm flesh, and has a lower content of long-chain arsenic acid than palm oil, which is excellent in improving skin elasticity as well as moisturizing the skin. show effect.
상기 수소화 팜 커널 오일의 함량이 1 중량부 미만이면 상기의 효과가 미미하며, 상기 수소화 팜 커널 오일의 함량이 5 중량부를 초과하게 되면 상기의 효과는 크게 향상되지 않으면서 다른 성분들의 상대적 함량이 줄어들어 화장료 조성물의 기능성이 저하될 수 있다.If the content of the hydrogenated palm kernel oil is less than 1 part by weight, the above effect is insignificant, and if the content of the hydrogenated palm kernel oil exceeds 5 parts by weight, the above effect is not greatly improved and the relative content of other components is reduced. The functionality of the cosmetic composition may decrease.
이하에서는, 본 발명에 따른 어성초를 이용한 피부개선용 화장료 조성물의 제조방법 및 그 제조방법으로 제조된 화장료 조성물의 물성을 실시예를 들어 설명하기로 한다.Hereinafter, the manufacturing method of the cosmetic composition for skin improvement using Hoseongcho according to the present invention and the physical properties of the cosmetic composition prepared by the manufacturing method will be described with examples.
<제조예 1> 어성초 추출물의 제조<Preparation Example 1> Preparation of Eoseongcho extract
정제수로 수세한 어성초 100 중량부 대비 질량농도가 95%인 에탄올 600 중량부를 혼합하고 상온에서 13시간 동안 추출한 후에 고형분을 여과하여 어성초 추출물을 제조하였다.Eoseongcho extract was prepared by mixing 600 parts by weight of ethanol having a mass concentration of 95% with respect to 100 parts by weight of Eoseongcho washed with purified water, extracting at room temperature for 13 hours, and filtering the solid content.
<제조예 2> 병풀 추출물의 제조<Preparation Example 2> Preparation of centella asiatica extract
건조된 병풀 잎 100 중량부를 2.5cm로 절단하고, 질량농도가 30%인 에탄올 1000 중량부를 혼합하고 상온에서 5일 동안 침적시키고, 고형분을 여과하여 병풀 추출물을 제조하였다.100 parts by weight of dried Centella asiatica leaves were cut into 2.5 cm, mixed with 1000 parts by weight of ethanol having a mass concentration of 30%, deposited at room temperature for 5 days, and the solid content was filtered to prepare a Centella asiatica extract.
<제조예 3> 인진쑥 추출물의 제조<Preparation Example 3> Preparation of Injin mugwort extract
건조된 인진쑥 100 중량부를 0.5cm로 분쇄하고, 질량농도가 50%인 프로필렌글리콜 600 중량부를 혼합하고 상온에서 5일 동안 침적시키고, 고형분을 여과하여 인진쑥 추출물을 제조하였다.100 parts by weight of dried Injin mugwort was pulverized to 0.5 cm, mixed with 600 parts by weight of propylene glycol having a mass concentration of 50%, deposited at room temperature for 5 days, and the solid content was filtered to prepare an extract of Injin mugwort.
<제조예 4> 청귤 추출물의 제조<Preparation Example 4> Preparation of green tangerine extract
건조된 청귤 100 중량부 0.5cm로 분쇄한 후에, 정제수 800 중량부를 혼합하고 12시간 동안 환류추출한 후에 여과하여 청귤추출물을 제조하였다.After pulverizing 100 parts by weight of dried green tangerine with 0.5 cm, 800 parts by weight of purified water was mixed, extracted under reflux for 12 hours, and then filtered to prepare a green tangerine extract.
<제조예 5> 갈락토미세스 발효물의 제조<Preparation Example 5> Preparation of Galactomyces fermented product
갈락토미세스에 유산균을 접종하고, 30℃의 온도에서 24시간 동안 발효하여 발효물을 제조한 후에, 상기 발효물에 함유된 균체를 파쇄한 후에 원심분리 및 여과하여 갈락토미세스 발효물을 제조하였다.Galactomyces was inoculated with lactic acid bacteria, fermented at a temperature of 30 ° C. for 24 hours to prepare a fermented product, and then the cells contained in the fermented product were disrupted, centrifuged and filtered to prepare a Galactomyces fermented product. .
<제조예 6> 천연 항염제의 제조<Preparation Example 6> Preparation of natural anti-inflammatory agent
자초 추출물 100 중량부, 치자 추출물 10 중량부, 연교 추출물 10 중량부, 고삼 추출물 10 중량부, 현삼 추출물 10 중량부 및 마치현 추출물 10 중량부를 혼합하여 천연 항염제를 제조하였다.A natural anti-inflammatory agent was prepared by mixing 100 parts by weight of perilla extract, 10 parts by weight of gardenia extract, 10 parts by weight of Yeongyo extract, 10 parts by weight of Kosam extract, 10 parts by weight of ginseng extract, and 10 parts by weight of portulaca extract.
<제조예 7> 천연 모공 축소제의 제조<Preparation Example 7> Preparation of natural pore shrinking agent
메밀 분말 100 중량부, 녹두 분말 10 중량부, 팥 분말 10 중량부, 율피 분말 10 중량부, 현미 분말 10 중량부, 감잎 분말 10 중량부 및 백지 분말 10 중량부를 혼합하여 천연 모공 축소제를 제조하였다.A natural pore shrinking agent was prepared by mixing 100 parts by weight of buckwheat powder, 10 parts by weight of mung bean powder, 10 parts by weight of red bean powder, 10 parts by weight of yulpi powder, 10 parts by weight of brown rice powder, 10 parts by weight of persimmon leaf powder, and 10 parts by weight of white paper powder. .
<실시예 1><Example 1>
상기 제조예 1을 통해 제조된 어성초 추출물 100 중량부에 상기 제조예 2를 통해 제조된 병풀추출물 12.5 중량부, 상기 제조예 3을 통해 제조된 인진쑥 추출물 12.5 중량부, 상기 제조예 4를 통해 제조된 청귤 추출물 8 중량부 및 상기 제조예 5를 통해 제조된 갈락토미세스 발효물 2.5 중량부를 교반기가 구비된 혼합당치에 투입하고 150rpm의 속도로 10분 동안 교반하여 어성초를 이용한 피부개선용 화장료 조성물을 제조하였다.100 parts by weight of the Hoseongcho extract prepared in Preparation Example 1, 12.5 parts by weight of Centella asiatica extract prepared in Preparation Example 2, 12.5 parts by weight of Artemisia extract prepared in Preparation Example 3, and prepared in Preparation Example 4 8 parts by weight of the green tangerine extract and 2.5 parts by weight of the fermented product of Galactomyces prepared in Preparation Example 5 were added to a mixed sugar mixture equipped with a stirrer and stirred at a speed of 150 rpm for 10 minutes to prepare a cosmetic composition for skin improvement using Hoseongcho. did
<실시예 2><Example 2>
상기 실시예 1과 동일하게 진행하되, 어성초 추출물 100 중량부, 병풀추출물 5 중량부, 인진쑥 추출물 5 중량부, 청귤 추출물 5 중량부 및 갈락토미세스 발효물 0.1 중량부를 혼합하여 어성초를 이용한 피부개선용 화장료 조성물을 제조하였다.Proceed in the same manner as in Example 1, but by mixing 100 parts by weight of Houttuynia cordata extract, 5 parts by weight of centella asiatica extract, 5 parts by weight of Injin mugwort extract, 5 parts by weight of green tangerine extract, and 0.1 part by weight of fermented product of Galactomyces for skin improvement using Houttuynia cordata A cosmetic composition was prepared.
<실시예 3><Example 3>
상기 실시예 1과 동일하게 진행하되, 어성초 추출물 100 중량부, 병풀추출물 20 중량부, 인진쑥 추출물 20 중량부, 청귤 추출물 20 중량부 및 갈락토미세스 발효물 5 중량부를 혼합하여 어성초를 이용한 피부개선용 화장료 조성물을 제조하였다.Proceed in the same manner as in Example 1, but by mixing 100 parts by weight of eoseongcho extract, 20 parts by weight of centella asiatica extract, 20 parts by weight of artemisia extract, 20 parts by weight of green tangerine extract, and 5 parts by weight of fermented galactomyces for skin improvement using eoseongcho A cosmetic composition was prepared.
<실시예 4><Example 4>
상기 실시예 1과 동일하게 진행하되, 상기 어성초 추출물 100 중량부 대비 상기 제조예 6을 통해 제조된 천연 항염제 2 중량부 및 상기 제조예 7을 통해 제조된 천연 모공 축소제 3.5 중량부를 더 혼합하여 어성초를 이용한 피부개선용 화장료 조성물을 제조하였다.Proceed in the same manner as in Example 1, but further mix 2 parts by weight of the natural anti-inflammatory agent prepared in Preparation Example 6 and 3.5 parts by weight of the natural pore shrinking agent prepared in Preparation Example 7 with respect to 100 parts by weight of the Hoseongcho extract. A cosmetic composition for skin improvement using was prepared.
<실시예 5><Example 5>
상기 실시예 1과 동일하게 진행하되, 어성초 추출물 100 중량부 대비 수소화 팜 커널 오일 3 중량부를 더 혼합하여 어성초를 이용한 피부개선용 화장료 조성물을 제조하였다.Proceed in the same manner as in Example 1, but by further mixing 3 parts by weight of hydrogenated palm kernel oil with respect to 100 parts by weight of Hoseongcho extract to prepare a cosmetic composition for improving skin using Hoseongcho.
<비교예 1><Comparative Example 1>
상기 실시예 1과 동일하게 진행하되, 어성초 추출물 100 중량부, 병풀추출물 1 중량부, 인진쑥 추출물 1 중량부, 청귤 추출물 1 중량부 및 갈락토미세스 발효물 0.01를 혼합하여 어성초를 이용한 피부개선용 화장료 조성물을 제조하였다.Proceed in the same manner as in Example 1, but mix 100 parts by weight of eoseongcho extract, 1 part by weight of centella asiatica extract, 1 part by weight of mugwort extract, 1 part by weight of green tangerine extract, and 0.01 part by weight of fermented product of Galactomyces, and use cosmetic for skin improvement using eoseongcho. A composition was prepared.
<비교예 2><Comparative Example 2>
상기 실시예 1과 동일하게 진행하되, 어성초 추출물 100 중량부, 병풀추출물 30 중량부, 인진쑥 추출물 30 중량부, 청귤 추출물 20 중량부 및 갈락토미세스 발효물 10 중량부를 혼합하여 어성초를 이용한 피부개선용 화장료 조성물을 제조하였다.Proceed in the same manner as in Example 1, but by mixing 100 parts by weight of eoseongcho extract, 30 parts by weight of centella asiatica extract, 30 parts by weight of artemisia extract, 20 parts by weight of green tangerine extract, and 10 parts by weight of fermented galactomyces for skin improvement using eoseongcho A cosmetic composition was prepared.
상기 실시예 1 내지 5 및 비교예 1 내지 2를 통해 제조된 어성초를 이용한 피부개선용 화장료 조성물의 보습, 피부탄력 및 모공개선 효과를 측정하여 아래 표 1에 나타내었다.The moisturizing, skin elasticity and pore improvement effects of the cosmetic composition for skin improvement using Hoseongcho prepared in Examples 1 to 5 and Comparative Examples 1 to 2 were measured and shown in Table 1 below.
{단, 보습은 피시험자 50명을 대상으로 온도 22℃, 상대습도 47%의 항온 항습실에서 화장료 조성물을 얼굴에 일정량(0.05g/20㎠) 도포하고, 도포 2시간 후에 피부 수분 함량을 수분 함량 측정기(Corneometer CM820 Courage-Khazaka, Koln, Germany)로 측정하는 방법을 이용하였다.{However, for moisturizing, a certain amount (0.05g/20cm2) of a cosmetic composition was applied to the face of 50 test subjects in a constant temperature and humidity room at a temperature of 22°C and a relative humidity of 47%, and the skin moisture content was measured 2 hours after application. A method of measuring with a measuring instrument (Corneometer CM820 Courage-Khazaka, Koln, Germany) was used.
또한, 피부탄력은 온도 22℃, 상대습도 55% 조건에서 20세 이상의 건강한 여성 50명(평균 연령 29.5세)을 5그룹으로 나누고, 화장료 조성물을 눈가를 중심으로 12주간 도포(2회/일)한 후, 피부탄력측정기(Cutometer SEM 575, C+K Electronic Co, Germany)를 이용하여 피부탄력을 측정하는 방법을 이용하였다.In addition, for skin elasticity, 50 healthy women aged 20 or older (average age 29.5 years old) were divided into 5 groups at a temperature of 22°C and relative humidity of 55%, and the cosmetic composition was applied around the eyes for 12 weeks (twice/day). After that, a method of measuring skin elasticity using a skin elasticity measuring device (Cutometer SEM 575, C+K Electronic Co, Germany) was used.
시험 결과는 Cutometer SEM 575의 각 시험 그룹별 평균값인 △R5값[R5(12주)-R5(0주)] 값으로 기재하였는데, R5 값은 실탄성 계수를 나타내는 값으로 1에 가까워지면 보다 탄력도가 우수함을 나타낸다.The test results were described as the △R5 value [R5 (12 weeks)-R5 (0 weeks)], which is the average value for each test group of Cutometer SEM 575. indicates excellence.
또한, 모공개선 효과는 0.3% 알부민을 0.05M 구연산 버퍼(pH 4.5)에 용해한 후, 0.3% 알부민 2mL에 농도 5%가 되도록 화장료 조성물을 가한 다음, 5분 동안 교반 후, 650nm에서 UV Visible spectrum으로 흡광도를 측정하는 방법을 이용하였다.}In addition, the pore improvement effect is obtained by dissolving 0.3% albumin in 0.05M citric acid buffer (pH 4.5), adding a cosmetic composition to 2mL of 0.3% albumin to a concentration of 5%, stirring for 5 minutes, and then using UV Visible spectrum at 650nm. A method for measuring absorbance was used.}
<표 1><Table 1>
상기 표 1에 나타낸 것처럼, 본 발명의 실시예 1 내지 5를 통해 제조된 화장료 조성물은 우수한 피부보습, 피부탄력 및 모공개선 효과를 나타내는 것을 알 수 있다.As shown in Table 1, it can be seen that the cosmetic compositions prepared in Examples 1 to 5 of the present invention exhibit excellent skin moisturizing, skin elasticity and pore improvement effects.
특히, 천연 모공 축소제가 함유된 실시예 4는 모공개선 효과가 월등하게 향상되었으며, 실시예 5는 수소화 팜 커널 오일이 함유되어 피부 보습 효과와 피부 탁력 개선 효과가 월등하게 향상되는 것을 알 수 있다.In particular, it can be seen that Example 4, which contains a natural pore-reducing agent, has a significantly improved pore-reducing effect, and Example 5, which contains hydrogenated palm kernel oil, significantly improves skin moisturizing effect and skin turbidity improvement.
따라서, 본 발명에 따른 어성초를 이용한 피부개선용 화장료 조성물은 피부 탄력, 피부 진정, 피부 노화방지, 피부 미백 및 피부 보습 효과를 나타낼 뿐만 아니라, 피부 염증을 개선하는 탁월한 효과를 나타낸다.Therefore, the cosmetic composition for skin improvement using Hoseongcho according to the present invention exhibits skin elasticity, skin soothing, skin aging prevention, skin whitening and skin moisturizing effects, and also exhibits an excellent effect of improving skin inflammation.
Claims (7)
A cosmetic composition for improving skin using Hoseongcho, characterized in that it consists of Houttuynia cordata extract, Centella asiatica extract, Injin mugwort extract, Green tangerine extract and Galactomyces fermented product.
상기 어성초를 이용한 피부개선용 화장료 조성물은 어성초 추출물 100 중량부, 병풀추출물 5 내지 20 중량부, 인진쑥 추출물 5 내지 20 중량부, 청귤 추출물 5 내지 10 중량부 및 갈락토미세스 발효물 0.1 내지 5 중량부로 이루어지는 것을 특징으로 하는 어성초를 이용한 피부개선용 화장료 조성물.
The method of claim 1,
The cosmetic composition for skin improvement using the Eoseongcho extract comprises 100 parts by weight of Eoseongcho extract, 5 to 20 parts by weight of centella asiatica extract, 5 to 20 parts by weight of Injin mugwort extract, 5 to 10 parts by weight of green tangerine extract, and 0.1 to 5 parts by weight of fermented Galactomyces. Cosmetic composition for skin improvement using Eoseongcho, characterized in that consisting of.
상기 갈락토미세스 발효물은 갈락토미세스에 유산균을 접종하고, 20 내지 40℃의 온도에서 20 내지 30시간 동안 발효하여 발효물을 제조한 후에, 상기 발효물에 함유된 균체를 파쇄한 후에 원심분리 및 여과하여 제조되는 것을 특징으로 하는 어성초를 이용한 피부개선용 화장료 조성물.
According to claim 1 or 2,
The Galactomyces fermented product is prepared by inoculating lactic acid bacteria into Galactomyces, fermenting at a temperature of 20 to 40 ° C. for 20 to 30 hours, and then crushing the cells contained in the fermented product and centrifuging And a cosmetic composition for skin improvement using Eoseongcho, characterized in that produced by filtration.
상기 어성초를 이용한 피부개선용 화장료 조성물에는 상기 어성초 추출물 100 중량부 대비 자초 추출물이 함유된 천연 항염제 1 내지 3 중량부 및 메밀이 함유된 천연 모공 축소제 2 내지 5 중량부가 더 함유되는 것을 특징으로 하는 어성초를 이용한 피부개선용 화장료 조성물.
The method of claim 1,
The cosmetic composition for skin improvement using the hoseongcho is characterized in that it further contains 1 to 3 parts by weight of a natural anti-inflammatory agent containing self-injection extract and 2 to 5 parts by weight of a natural pore shrinking agent containing buckwheat compared to 100 parts by weight of the hoseongcho extract Cosmetic composition for skin improvement using Eoseongcho.
상기 천연 항염제는 자초 추출물, 치자 추출물, 연교 추출물, 고삼 추출물, 현삼 추출물 및 마치현 추출물로 이루어지는 것을 특징으로 하는 어성초를 이용한 피부개선용 화장료 조성물.
The method of claim 4,
The natural anti-inflammatory agent is a cosmetic composition for skin improvement using Eoseongcho, characterized in that consisting of self-injection extract, gardenia extract, yeongyo extract, gosam extract, ginseng extract and portulaca extract.
상기 천연 모공 축소제는 메밀 분말, 녹두 분말, 팥 분말, 율피 분말, 현미 분말, 감잎 분말 및 백지 분말로 이루어지는 것을 특징으로 하는 어성초를 이용한 피부개선용 화장료 조성물.
The method of claim 4,
The natural pore reducing agent is a cosmetic composition for skin improvement using Eoseongcho, characterized in that consisting of buckwheat powder, mung bean powder, red bean powder, yulpi powder, brown rice powder, persimmon leaf powder and white paper powder.
상기 어성초를 이용한 피부개선용 화장료 조성물에는 상기 어성초 추출물 100 중량부 대비 수소화 팜 커널 오일 1 내지 5 중량부가 더 함유되는 것을 특징으로 하는 어성초를 이용한 피부개선용 화장료 조성물.The method of claim 1,
The cosmetic composition for skin improvement using Eoseongcho, characterized in that it further contains 1 to 5 parts by weight of hydrogenated palm kernel oil relative to 100 parts by weight of the Eoseongcho extract.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210059311A KR20220151952A (en) | 2021-05-07 | 2021-05-07 | Cosmetic composition for skin improvement using houttuynia cordata |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210059311A KR20220151952A (en) | 2021-05-07 | 2021-05-07 | Cosmetic composition for skin improvement using houttuynia cordata |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20220151952A true KR20220151952A (en) | 2022-11-15 |
Family
ID=84041977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210059311A KR20220151952A (en) | 2021-05-07 | 2021-05-07 | Cosmetic composition for skin improvement using houttuynia cordata |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20220151952A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101858464B1 (en) | 2015-12-08 | 2018-05-16 | (주)셀바이오 | Cosmetic compositions containing Desmodii Herba extaracts for prevention of skin aging and improvement of skin wrinkle |
KR102236253B1 (en) | 2021-01-19 | 2021-04-05 | 김현숙 | Cosmetic composition for skin improvement comprising extracts derived from natural products and method for manufacturing the same |
-
2021
- 2021-05-07 KR KR1020210059311A patent/KR20220151952A/en not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101858464B1 (en) | 2015-12-08 | 2018-05-16 | (주)셀바이오 | Cosmetic compositions containing Desmodii Herba extaracts for prevention of skin aging and improvement of skin wrinkle |
KR102236253B1 (en) | 2021-01-19 | 2021-04-05 | 김현숙 | Cosmetic composition for skin improvement comprising extracts derived from natural products and method for manufacturing the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110292552B (en) | Compound plant extract with anti-allergy repairing effect and preparation method and application thereof | |
CN105902454B (en) | One kind being used for the regenerated Moringa compound Essence of cell repair | |
KR102006708B1 (en) | Soap composition using wood-cultivated ginseng and soap comprising the same | |
CN104784507A (en) | Traditional Chinese medicine composition with multiple cosmetic effects and application | |
KR102054793B1 (en) | Cosmetic composition Cosmetic for improving skin elasticity and reducing dark circles containing natural extract and fermented extract | |
CN104644528B (en) | A kind of preparation method and application of edible moisture-keeping nutrient ointment | |
KR101816725B1 (en) | Manufacturing method for fermented extracts and cosmetic composition comprising fermented extracts | |
CN110585029A (en) | Traditional Chinese medicine herbal mask powder and preparation method and use method thereof | |
CN108670933B (en) | Skin care composition with moisturizing, whitening and anti-aging functions and application thereof | |
CN112137919B (en) | Application of dictyophora indusiata egg extract in preparation of external beauty and skin care products and external beauty and skin care products based on same | |
CN109620779A (en) | A kind of anti-acne moisturizing cosmetic face cream and preparation method thereof | |
KR102176938B1 (en) | Cosmetic Composition Comprising Fermented Liquor of Natural Plant and Preparation Methods Thereof | |
CN103550129B (en) | Plant composite polysaccharide, Preparation Method And The Use | |
KR102054100B1 (en) | Cosmetic composition containing fermented extract of roots | |
KR101662272B1 (en) | Natural cosmetic composition for skin moisturizing comprising Mixed extract of barley and germ and rice bran of black rice and preparation method thereof | |
CN106176360A (en) | A kind of nectar frost containing oral shui solution extract, Herba Saussureae Involueratae extract and Echinacea Angustifolia extracts and preparation method thereof | |
KR101710005B1 (en) | Cosmetic composition comprising cheonjeongpalgindan as active ingredient | |
KR102303400B1 (en) | Preparation Methods of Fermentation Products Using JEJU Lava Seawater, JEJU Barley Yeast and Natural Plant and Cosmetic Compositions Having Thereof | |
CN104490702A (en) | Herbal mask taking plant extract as anticorrosive antibacterial additive | |
KR20220151952A (en) | Cosmetic composition for skin improvement using houttuynia cordata | |
KR102308756B1 (en) | Cosmetic Composition Containing Mixture Extracts of Citrus Unshiu Peel Extract and Andrographis Paniculata As Active Ingrediend | |
KR20230152511A (en) | Cosmetic composition in relieving skin for skin regenerating, Manufacturing method thereof, and Cosmetics containing the same | |
CN109646359B (en) | Rose-agaric mud membrane paste with effects of cleaning, purifying, maintaining beauty and keeping young and preparation method thereof | |
CN113908087A (en) | Natural moisturizing combined extract, preparation method and application thereof | |
CN111265443A (en) | Anti-aging essence skin care lotion containing codonopsis pilosula extract and preparation method of anti-aging essence skin care lotion |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
N231 | Notification of change of applicant | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |